MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.03.2026
22nd Century Group ROE 2011-2026 | XXII
ROE Jährlich 22nd Century Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.07 | -377.97 | 1673.9 | -62.31 | -7.61 | -44.69 | -42.8 | -11.18 | -17.27 | -47.59 | -94.06 | -102.47 | -347.65 | 109.85 | 111.14 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1673.9 | -377.97 | 47.15 |
ROE Vierteljährlich 22nd Century Group
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -258.24 | -396.33 | -219.37 | 57.6 | -469.54 | -888.48 | -1033.22 | -578.0 | -588.82 | -72.5 | -55.77 | -37.77 | -49.71 | -50.84 | -44.06 | -26.31 | -40.83 | -38.45 | -45.14 | -44.69 | -40.16 | -47.1 | -48.59 | -42.8 | -45.33 | -19.97 | -16.46 | -11.18 | -3.62 | -16.86 | -11.85 | -17.27 | -23.61 | -30.22 | -37.7 | -47.59 | -60.73 | -73.27 | -72.33 | -94.06 | -106.36 | -96.35 | -98.28 | -98.1 | -265.72 | -456.53 | -449.54 | -243.68 | -236.36 | -24.69 | -21.08 | 39.63 | 78.0 | 109.05 | 202.09 | 182.67 | 38.37 | 90.74 | 53.57 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 202.09 | -1033.22 | -117.69 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
63.85 | $ 0.82 | -1.38 % | $ 37.5 M |  Israel |
 |
Exelixis
EXEL
|
36.21 | $ 46.5 | -4.52 % | $ 12.6 B | USA |
 |
Fortress Biotech
FBIO
|
13.66 | $ 2.47 | -3.18 % | $ 68.9 M | USA |
 |
Heron Therapeutics
HRTX
|
-140.9 | $ 1.24 | -5.73 % | $ 207 M | USA |
 |
InflaRx N.V.
IFRX
|
-109.81 | $ 2.67 | 6.8 % | $ 180 M | Germany |
 |
Ionis Pharmaceuticals
IONS
|
-46.9 | $ 76.1 | -0.98 % | $ 12.2 B | USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 93.73 | -1.61 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | USA |
 |
Kymera Therapeutics
KYMR
|
-19.71 | $ 86.13 | -0.15 % | $ 7.28 B | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
-0.49 | $ 212.22 | -8.74 % | $ 3.88 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 22.18 | 3.26 % | $ 3.68 B | USA |
 |
Liquidia Corporation
LQDA
|
-154.03 | $ 42.07 | -0.17 % | $ 3.62 B | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
7.51 | $ 3.15 | - | $ 655 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
-7.42 | $ 101.66 | -7.65 % | $ 5.1 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.63 | 8.36 % | $ 5.98 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
MannKind Corporation
MNKD
|
-11.49 | $ 3.65 | 2.39 % | $ 1.12 B | USA |
 |
Genprex
GNPX
|
-203.83 | $ 0.89 | 0.28 % | $ 830 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Genmab A/S
GMAB
|
24.88 | $ 27.58 | -1.11 % | $ 17 B |  Danmark |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-214.18 | $ 0.65 | -4.03 % | $ 3.56 M | USA |
 |
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Nanobiotix S.A.
NBTX
|
-47.67 | $ 42.53 | 1.6 % | $ 286 B | France |
 |
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 22.31 | -7.72 % | $ 2.84 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | USA |